a comparative study of a locally placed drug and yoga with and without another oral drug in cases of yoni vyapad w.s.r to perineal laxity.

Phase 2/3

Not yet recruiting

• Conditions: Incomplete uterovaginal prolapse. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,

• Registration Number: CTRI/2023/06/053711
• Lead Sponsor: STATE AYURVEDIC COLLEGE and HOSPITAL LUCKNOW

Brief Summary

In Ayurveda, Aachryas’ have mentioned 20 types of yonivyapad which includes almost all types of gynaecological disorders due to vitiation of vata, pitta, kapha. Yoni bhransh is mentioned as a symptom of phalani, vatiki, prasramsini yoni vyapad. Yoni bhransh resembles with uterine prolapse and vaginal wall prolapse. It is a common condition which arises due to weakness of the supporting structures of female pelvis. It is characterized by descent of one or more of the pelvic organs through the potential space of vagina, heaviness in pelvic region, vaginal discharges, dyspareunia, painful, burning micturition. Purpose of this study is to evaluate role of udumbaradi pottali, phalaghrita nd yoga intervention for better therapeutic responses. All patients will be registered from OPD. Registered patients will be randomly divided into two groups. GROUP A patients will be given trial drug phalaghrita orally for 3 continuous months and udumbaradi pottali locally for 10 days for 3 months with yoga intervention for 30 minutes. GROUP B patients will be given the trial drug udumbaradi pottali for 10 days for 3 months along with yoga intervention. Followup will be done in every 15 days.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-06-30
• Last Update Posted: 2023-12-19

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

1.patient fulfilling cardinal symptoms of Yoni Bhransh; 2.patient having cystocele and rectocele; 3.multiparous women;.

Exclusion Criteria

• Patient with vaginal infection; 2.
• Complete procidentia; 3.
• Patient who have completed their family; 4.
• Patient having systemic diseases like hypertension, diabetes mellitus, thyroid disorder with the present study; 5.
• Pregnant and lactating women; 6.
• Patients with OCPs and IUCDs; 7.
• Patient with any pelvic pathology or malignancy of genital organs.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
2. Relief in pain in back and lower abdomen and also pain during movement.	90 days
1. Relief in painful and burning micturition;	90 days

Secondary Outcome Measures

Name	Time	Method
1. Relief in feeling of heaviness in pelvic region;	2. Relief in vaginal discharge with heaviness in pelvic region.

Trial Locations

Locations (1)

state ayurvedic college and hospital; 🇮🇳 Lucknow, UTTAR PRADESH, India

state ayurvedic college and hospital

🇮🇳Lucknow, UTTAR PRADESH, India

Dr Vibha Parihar

Principal investigator

9452196405

vibha24parihar@gmail.com